Alphatec Hldgs Inc Stock Price, News & Analysis

Alphatec Holdings (NASDAQ: ATEC) has launched the InVictus OsseoScrew Expandable Spinal Fixation System, a state-of-the-art solution designed to enhance spinal fixation in patients with compromised bone quality. This system achieves a 29% increase in pull-out strength compared to conventional screws. Clinical studies indicate that it provides comparable fusion and stability outcomes while mitigating risks associated with cement leakage. The InVictus platform aims to address unmet clinical needs in spine surgery, ensuring safer and more effective patient care.

Alphatec Holdings, Inc. (NASDAQ: ATEC) provided an update on its business amidst the COVID-19 pandemic, which has affected surgical volumes in the spine sector during Q3 2021. Despite lower than expected overall procedure volumes, ATEC anticipates over 25% year-over-year spine revenue growth for the quarter, although revenue will decline sequentially from Q2. The company continues to integrate EOS imaging technology and remains focused on advancing spine surgery innovation. ATEC plans to showcase its solutions at the upcoming NASS 2021 meeting.

Alphatec Holdings, Inc. (NASDAQ: ATEC) announced participation in the North American Spine Society's Annual Meeting from September 29 to October 1, 2021. The event will highlight the company’s innovative spine solutions, including the Prone TransPsoas (PTP) technique and EOS imaging technology. ATEC aims to demonstrate the clinical utility of these advancements through presentations by leading spine surgeons at booth #2308. CEO Pat Miles emphasized ATEC's commitment to revolutionizing spine surgery.

Alphatec Holdings, Inc. (Nasdaq: ATEC) announced that Pat Miles, Chairman and CEO, and Todd Koning, CFO, will participate in two investor conferences. The first is the H.C. Wainwright 23rd Annual Global Investment Conference, featuring a virtual presentation available from September 13-15, 2021. The second is The Cantor Virtual Global Healthcare Conference on September 27, 2021, at 4:40 pm ET. Webcasts and presentation copies will be accessible on the company's investor relations website for 90 days.

ATEC aims to transform spine surgery with its innovative solutions.

Alphatec Holdings, Inc. (Nasdaq: ATEC) has priced a private offering of $275 million in 0.75% convertible senior notes due 2026, increased from a previous $250 million. The notes will settle on August 10, 2021, and yield semi-annual interest. Notably, the initial conversion price represents a premium of 32.5% over recent stock prices. Proceeds will fund capped call transactions, share repurchases of $25 million, and debt repayment. Alphatec’s financial maneuvers aim to minimize stock dilution and enhance shareholder value, although market conditions pose inherent risks.

Alphatec Holdings, Inc. (Nasdaq: ATEC) has announced a private offering of $250 million in convertible senior notes due 2026. The offering may include an additional $37.5 million, subject to market conditions. The notes will accrue interest and can be converted into common stock under certain conditions. Proceeds will be used for capped call transactions, share repurchases worth up to $25 million, and repaying loans totaling approximately $53.4 million. The notes will not be registered under securities laws and are offered only to qualified institutional buyers.

Alphatec Holdings, Inc. (ATEC) reported Q2 2021 financial results, revealing total revenues of $62.2 million and a GAAP gross margin of 66.0%. Operating expenses reached $76.8 million, resulting in a GAAP operating loss of $(35.8 million). Notably, 84% of revenue stemmed from new products, up from 61% in Q2 2020. The company forecasts $238 million in total revenue for the fiscal year, a 64% increase year-over-year. The recent acquisition of EOS imaging aims to enhance ATEC's clinical capabilities.

Alphatec Holdings, Inc. (ATEC), a leader in innovative spine surgery solutions, announced their participation in several investor conferences. Key events include:

• Canaccord Genuity 41st Annual Growth Conference on August 11, 2021, at 2:30 pm ET
• UBS Genomics 2.0 and MedTech Innovations Summit on August 12, 2021, at 3:00 pm ET
• 6th Annual Needham Virtual MedTech Conference on August 16, 2021
• Piper Sandler MedTech and Diagnostics California Bus Tour on August 25, 2021

Webcasts of these presentations will be available on ATEC's Investor Relations page for 90 days.

Alphatec Holdings, Inc. (ATEC) announced the appointment of Beth Altman as an independent director and Chair of the Audit Committee, effective August 12, 2021. Altman, previously Managing Partner at KPMG LLP San Diego, brings extensive expertise in life sciences and technology. The company also shared the resignation of Donald A. Williams from the Board, effective August 11, 2021. Pat Miles, Chairman and CEO, emphasized Altman's significance in ATEC's transformation into a leading spine company.